Source: Abstracts. Conference titles: International Congress of Immunology. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, CARCINOMA DE CÉLULAS ESCAMOSAS, CITOCINAS
ABNT
VICTORA, G. D. et al. Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial. 2007, Anais.. Rio de Janeiro: Faculdade de Medicina, Universidade de São Paulo, 2007. p. 19. . Acesso em: 21 ago. 2024.APA
Victora, G. D., Coelho, V. P. C. V., Socorro-Silva, A., Volsi, E. C., Abdallah, K., Lima, F. D., et al. (2007). Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial. In Abstracts (p. 19). Rio de Janeiro: Faculdade de Medicina, Universidade de São Paulo.NLM
Victora GD, Coelho VPCV, Socorro-Silva A, Volsi EC, Abdallah K, Lima FD, Michaluart Junior P, Kalil J, Rodrigues Junior JM, Lima KM, Silva CL. Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial. Abstracts. 2007 ; 19.[citado 2024 ago. 21 ]Vancouver
Victora GD, Coelho VPCV, Socorro-Silva A, Volsi EC, Abdallah K, Lima FD, Michaluart Junior P, Kalil J, Rodrigues Junior JM, Lima KM, Silva CL. Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial. Abstracts. 2007 ; 19.[citado 2024 ago. 21 ]